Immunogenicity of Pneumococcal Revaccination inpatients with Chronic Disease

摘要

This study supports revaccinating high-risk elderly patients whose pneu-mococcal antibody levels are likely to decline over time. Revaccination 6 years after the primary vaccination generates antibody tilers that are comparable to those resulting from initial vaccination.